p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 744-749

  Shida, Yohei ^a   Igawa, Tsukasa ^a   Hakariya, Tomoaki ^a   Sakai, Hideki ^a   Kanetake, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

DU145 cells; IL 6; JNK; p38MAPK; PC 3 cells; Prostate cancer; SAPKs

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANDROGEN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ANDROGENS; ANTHRACENES; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; IMIDAZOLES; INTERLEUKIN-6; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTATIC NEOPLASMS; PYRIDINES; RITODRINE;

EID: 33846021570     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.077     Document Type: Article

References (29)

1. Crawford E.D., Rosenblum M., Ziada A.M., and Lange P.H. Hormone refractory prostate cancer. Urology 54 (1999) 1-7
2. Isaacs J.T. The biology of hormone refractory prostate cancer, Why does it develop?. Urol. Clin. North Am. 26 (1999) 263-273
3. Abate-Shen C., and Shen M.M. Molecular genetics of prostate cancer. Genes Dev. 14 (2000) 2410-2434
4. M.J. Pilat, J.M. Kamradt, K.J. Pienta, Hormone resistance in prostate cancer, Cancer Metastasis Rev. 17 (1998-1999) 373-381.
5. Nakashima J., Tachibana M., Horiguchi Y., Oya M., Ohigashi T., Asakura H., et al. Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin. Cancer Res. 6 (2000) 2702-2706
6. Qiu Y., Robinson D., Pretlow T.G., and Kung H.J. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc. Natl. Acad. Sci. USA 95 (1998) 3644-3649
7. Qiu Y., Ravi L., and Kung H.J. Requirement of ErbB2 for signaling by interleukin-6 in prostate carcinoma cells. Nature 393 (1998) 83-85
8. Lee S.O., Lou W., Johnson C.S., Trump D.L., and Gao A.C. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. Prostate 60 (2004) 178-186
9. Smith P.C., and Keller E.T. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice. Prostate 48 (2001) 47-53
10. Culig Z., Steiner H., Bartsch G., and Hobisch A. Interleukin-6 regulation of prostate cancer cell growth. J. Cell Biochem. 95 (2005) 497-505
11. Uzgare A.R., and Isaacs J.T. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal epithelial cells. Cancer Res. 64 (2004) 6190-6199
12. Barton B.E., Karras J.G., Murphy T.F., Barton A., and Huang H. Signal transducer and activator transcription (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol. Cancer Ther. 3 (2004) 11-20
13. Hideshima T., Nakamura N., Chauhan D., and Anderson K.C. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 20 (2001) 5991-6000
14. Wang C.B., Wong C.K., Ip W.K., Li M.L., Tian Y.P., and Lam C.W. Induction of IL-6 in co-culture of bronchial epithelial cells and eosinophils is regulated by p38 MAPK and NF-kappaB. Allergy 60 (2005) 1378-1385
15. de Haij S., Bakker A.C., van der Geest R.N., Haegeman G., Vanden Berghe W., Aarbiou J., et al. NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase. J. Am. Soc. Nephrol. 16 (2005) 1603-1611
16. Hakariya T., Shida Y., Sakai H., Kanetake H., and Igawa T. EGFR signaling pathway negatively regulates PSA expression and secretion via the PI3K-Akt pathway in LNCaP prostate cancer cells. Biochem. Biophys. Res. Commun. 342 (2006) 92-100
17. Engelberg D. Stress-activated protein kinases-tumor suppressors or tumor initiators?. Semin. Cancer Biol. 14 (2004) 271-282
18. Ono K., and Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 12 (2000) 1-13
19. Yang Y.M., Bost F., Charbono W., Dean N., McKay R., Rhim J.S., et al. C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin. Cancer Res. 9 (2003) 391-401
20. Rodrigues G.A., Park M., and Schlessinger J. Activation of the JNK pathway is essential for transformation by the Met Oncogene. EMBO. J. 16 (1997) 2634-2645
21. Kumar S., Boehm J., and Lee J.C. p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2 (2003) 717-726
22. Esteva F.J., Sahin A.A., Smith T.L., Yang Y., Pusztai L., Nahta R., et al. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer 100 (2004) 499-506
23. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
24. Maroni P.D., Koul S., Meacham R.B., and Koul H.K. Mitogen activated protein kinase signal transduction pathways in the prostate. Cell Commun. Signal. 2 (2004) 5
25. Uzgare A.R., Kaplan P.J., and Greenberg N.M. Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Prostate 55 (2003) 128-139
26. Igawa T., Lin F.F., Lee M.S., Karan D., Batra S.K., and Lin M.F. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate 50 (2002) 222-235
27. Signoretti S., Montironi R., Manola J., Altimari A., Tam C., Bubley G., et al. Her-2-neu expression and progression toward androgen independence in human prostate cancer. J. Natl. Cancer Inst. 92 (2000) 1918-1925
28. Park J.I., Lee M.G., Cho K., Park B.J., Chae K.S., Byun D.S., et al. Transforming growth factor-beta 1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 22 (2003) 4314-4332
29. Uehara T., Peng X.X., Bennett B., Satoh Y., Friedman G., Currin R., et al. c-JunN-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 78 (2004) 324-332